about
Standard and Guidelines: Intracranial Dural Arteriovenous Shunts.Progression of unilateral moyamoya disease: A clinical series.Histopathological findings following pipeline embolization in a human cerebral aneurysm at the basilar tipStandard of practice: embolization of ruptured and unruptured intracranial aneurysms.Reporting standards for endovascular chemotherapy of head, neck and CNS tumors.Vertebral augmentation: report of the Standards and Guidelines Committee of the Society of NeuroInterventional Surgery.Standards of practice and reporting standards for carotid artery angioplasty and stenting.Platelet function inhibitors and platelet function testing in neurointerventional procedures.Small pipes: preliminary experience with 3-mm or smaller pipeline flow-diverting stents for aneurysm repair prior to regulatory approval.Rate-programming of nano-particulate delivery systems for smart bioactive scaffolds in tissue engineering.A novel multi-modal platform to image molecular and elemental alterations in ischemic stroke.Computational nanomedicine for mechanistic elucidation of bilayer nanoparticle-mediated release for tissue engineering.Placebo power.Synchrotron-based intra-venous K-edge digital subtraction angiography in a pig model: a feasibility study.Dual energy CT at the synchrotron: a piglet model for neurovascular research.Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article.Surgical management of posterior fossa arteriovenous malformations.Inclusion of attentional networks in the pre-surgical neuroimaging assessment of a large deep hemispheric cavernous malformation: an FMRI case report.Impact of WASID and Wingspan on the frequency of intracranial angioplasty and stenting at a high volume tertiary care hospital.Guidelines and parameters: percutaneous sclerotherapy for the treatment of head and neck venous and lymphatic malformations.Canadian experience with the pipeline embolization device for repair of unruptured intracranial aneurysms.UV-Assisted 3D Bioprinting of Nanoreinforced Hybrid Cardiac Patch for Myocardial Tissue Engineering.The future of endovascular treatment: Insights from the ESCAPE investigators.Revealing the Penumbra through Imaging Elemental Markers of Cellular Metabolism in an Ischemic Stroke Model.Bioprinting Pattern-Dependent Electrical/Mechanical Behavior of Cardiac Alginate Implants: Characterization and Ex Vivo Phase-Contrast Microtomography Assessment.Potential of propagation-based synchrotron X-ray phase-contrast computed tomography for cardiac tissue engineering.Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial.Concurrent Glycogen and Lactate Imaging with FTIR Spectroscopy To Spatially Localize Metabolic Parameters of the Glial Response Following Brain Ischemia.Reorganized neural activation in motor cortex following subdural fluid collection: an fMRI and DTI study.Regulation of sequential release of growth factors using bilayer polymeric nanoparticles for cardiac tissue engineering.Optimization of nanoparticles for cardiovascular tissue engineering.Canadian Registry of LVIS Jr for Treatment of Intracranial Aneurysms (CaRLA).Importance of Developing Stroke Systems of Care to Improve Access to Endovascular Therapies.International retrospective study of the pipeline embolization device: a multicenter aneurysm treatment study.New Pipeline Flex device: initial experience and technical nuances.A comparison of parametric and integrative approaches for X-ray fluorescence analysis applied to a Stroke modelDelayed symptomatic coil migration after initially successful balloon-assisted aneurysm coiling: technical case reportCumulative radiation dose during hospitalization for aneurysmal subarachnoid hemorrhageTraumatic ophthalmic artery pseudoaneurysm coiled with a steerable microcatheterDynaCT evaluation of in-stent restenosis following Wingspan stenting of intracranial stenosis
P50
Q30278003-5329BD33-8666-4BB5-A235-D76610BBB603Q36473676-48EF0220-13D2-4472-BBB2-CEC60427B467Q37173810-A86A0AA0-99D9-4153-8851-336BF302B35EQ38098156-ED80C95D-F6D3-45CD-8881-BE77DF7F35A6Q38119427-7A2848C1-2205-4034-B112-C42EC7845D58Q38160426-F5BA9AEA-C692-473D-AE09-A57926DFB01BQ38160431-D224E28B-F7E1-4BBD-A157-EA9F155294F1Q38233284-D3195B4C-1A32-4E64-B7B9-E6A9B5173855Q38268079-111938F8-6BB0-4F96-8AE8-249E0213D45AQ38283046-AACA95BD-D12E-4D2B-8FDB-94C2902631F6Q38896260-E3D06ADA-C0D0-4468-8273-669156881460Q38967763-242455B1-8FF6-456F-BA55-E10E8A0B5150Q39612283-CDB5EA5C-1EE0-4001-B2DE-4BA00F98E004Q39874759-2A19C9C5-3355-4F53-BBEA-D3416CEE12E3Q39947390-4D42727C-492B-4F08-8AFF-9F9DD764D262Q39977528-EC92D820-3BB1-448B-A17D-7341D6E0EEF4Q40337292-3B19DA94-7A29-4AC2-AB50-11646FAA12BBQ42474491-C78A5588-6FA9-4A03-A8C3-517974FAF127Q42726085-855D5C31-5B07-43D7-8F30-6639B2A9676AQ46174341-58BB2B1E-B6E9-4B78-906E-B81C7CC638CFQ47308360-2C516EC7-CB62-4261-B867-B6CC4A1B4C5BQ47428869-DE22BF5D-7028-472D-97D5-FAF342569443Q47568897-5DB5CCA0-26DF-4C2D-80C0-06805FBA7572Q47839732-141C8A74-D93E-4BCF-905F-5350F4B15A93Q47904062-6DFE497E-D635-41FC-9E98-25C788B61335Q47971377-BA2DFFF4-53EA-4985-8E69-1745BA4FE987Q48342501-D2A9EA97-3C45-4773-AFB3-02BB98FC43D1Q48444750-BAB0D719-4812-4B25-8214-518189D85AA1Q50074760-48A0AEBB-80DF-4530-98F3-F66EA1562944Q50547397-733DF749-E8BB-450F-B8C5-41B4D54C92E5Q50912168-728120CD-AB20-431F-91DA-D4D2BF3CB35EQ51191561-6B424E21-EED5-4438-8768-018B9B2F78AEQ51467900-5D045727-C168-4C53-BCF8-1C86245D5B58Q53082362-0C91F6D2-5D86-45E3-860C-093B622AC9C8Q53425807-FADA2F86-9D0B-480E-AFD8-079174AB3755Q58563110-6D58EA9D-0EDB-4B77-8CF4-9FC88085EBC8Q83289854-A678528E-BC5A-465A-9168-140E65E5B0B7Q84317228-6785833E-7880-41CB-8C59-FBE57B15E449Q84338934-1190E1B9-F102-4BE8-A2BE-15E758A8B78FQ85078308-82A5FBEF-EF2F-4F56-8CA9-4B84B21DB688
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Michael E Kelly
@en
Michael E Kelly
@nl
type
label
Michael E Kelly
@en
Michael E Kelly
@nl
prefLabel
Michael E Kelly
@en
Michael E Kelly
@nl
P108
P31
P496
0000-0002-3278-2620